Alex Sapir, incoming Fulcrum Therapeutics CEO

Still un­der clin­i­cal hold, Ful­crum locks in sea­soned com­mer­cial leader as CEO

Ful­crum Ther­a­peu­tics has re­cruit­ed a new chief ex­ec­u­tive well versed in the mar­ket­ing world amid man­age­ment up­heaval, a full clin­i­cal hold for its sick­le cell …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.